Posterior Reversible Encephalopathy Syndrome Developing after Aggressive Posterior Fossa Tumor Surgery

Abstract

Posterior reversible encephalopathy syndrome (PRES) is a rare neurologic disorder, having such common radiological findings as vasogenic edema and white matter changes in watershed areas. The clinic and radiological outcome may not be reversible in 10 to 20% of patients, like in the case of our patient. Here, we discuss the pathogenetic factors that are essential in developing PRES after posterior fossa surgery. A 4-year-old female was admitted to our clinic with a recurrent/residual mass in the posterior fossa. She previously underwent posterior fossa surgery three times (for what was diagnosed as anaplastic astrocytoma through pathohistology) in another center. She was operated thrice in 5 days, and the tumor radically removed. Two days later, after the last surgery, while waking up, our patient developed seizures and altered consciousness. Her neurological condition was severe. Magnetic resonance imaging findings were compatible with those of PRES. Our patient had multiple risk factors for PRES that were as follows: multiple posterior fossa surgeries, anamnesis of chemotherapy and radiotherapy, high-dose steroid use, intracranial pressure changes, and hypertensive attacks due to surgical manipulation. In preventing the development of PRES, we should beware of sudden changes in blood pressure during surgery and meticulously manipulate the brain stem to avoid any disturbance of the central nervous system homeostasis. PRES may transform into real encephalopathy. If the patient has some of these risk factors, PRES would probably develop after surgery.

Keywords

anaplastic ependymoma - brain stem compression - posterior fossa surgery - posterior reversible encephalopathy syndrome (PRES)

Ethical Approval

Informed written consent was obtained from the parents of the patient for publication of this case report and any accompanying images.

Authors' Contributions

Orkhan Mammadkhanli and Gokhan Bozkurt were involved in the conception and design; acquisition, analysis, and interpretation of data; drafting; revising; and final approval of the manuscript. Mahmut Ozden contributed to the acquisition, analysis, and interpretation of data.

Publication History

Article published online:
08 October 2022

• References

• 1 Hinchey J, Chaves C, Appignani B. et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996; 334 (08) 494-500
• 2 Patel AJ, Fox BD, Fulkerson DH. et al. Posterior reversible encephalopathy syndrome during posterior fossa tumor resection in a child. J Neurosurg Pediatr 2010; 6 (04) 377-380
• 3 Moriarity Jr JL, Lim M, Storm PB, Beauchamp Jr NJ, Olivi A. Reversible posterior leukoencephalopathy occurring during resection of a posterior fossa tumor: case report and review of the literature. Neurosurgery 2001; 49 (05) 1237-1239 , discussion 1239–1240
• 4 Le EM, Loghin ME. Posterior reversible encephalopathy syndrome: a neurologic phenomenon in cancer patients. Curr Oncol Rep 2014; 16 (05) 383
• 5 Parikh NS, Schweitzer AD, Young RJ. et al. Corticosteroid therapy and severity of vasogenic edema in posterior reversible encephalopathy syndrome. J Neurol Sci 2017; 380: 11-15
• 6 Santillan A, Aamodt W, Bhavaraju-Sanka R. Pearls & Oysters: Spontaneous intracranial hypotension and posterior reversible encephalopathy syndrome. Neurology 2016; 86 (06) e55-e57
• 7 Niwa R, Oya S, Nakamura T, Hana T, Matsui T. Rapid intracranial pressure drop as a cause for posterior reversible encephalopathy syndrome: two case reports. Surg Neurol Int 2017; 8: 103
• 8 Lamy C, Oppenheim C, Mas JL. Posterior reversible encephalopathy syndrome. Handb Clin Neurol 2014; 121: 1687-1701
• 9 Geiger H, Naraghi R, Schobel HP, Frank H, Sterzel RB, Fahlbusch R. Decrease of blood pressure by ventrolateral medullary decompression in essential hypertension. Lancet 1998; 352 (9126): 446-449
• 10 Kan P, Couldwell WT. Posterior fossa brain tumors and arterial hypertension. Neurosurg Rev 2006; 29 (04) 265-269 , discussion 269
• 11 Coffee RE, Nicholas JS, Egan BM, Rumboldt Z, D'Agostino S, Patel SJ. Arterial compression of the retro-olivary sulcus of the medulla in essential hypertension: a multivariate analysis. J Hypertens 2005; 23 (11) 2027-2031
• 12 Delgado-López PD, Corrales-García EM, Alonso-García E. et al. Central nervous system ependymoma: clinical implications of the new molecular classification, treatment guidelines and controversial issues. Clin Transl Oncol 2019; 21 (11) 1450-1463
• 13 Gephart MG, Taft BP, Giese AK, Guzman R, Edwards MS. Perioperative posterior reversible encephalopathy syndrome in 2 pediatric neurosurgery patients with brainstem ependymoma. J Neurosurg Pediatr 2011; 7 (03) 235-237
• 14 Kamiya-Matsuoka C, Cachia D, Olar A, Armstrong TS, Gilbert MR. Primary brain tumors and posterior reversible encephalopathy syndrome. Neurooncol Pract 2014; 1 (04) 184-190
• 15 Sorour M, Sayama C, Couldwell WT. Posterior reversible encephalopathy syndrome after surgical resection of a giant vestibular schwannoma: case report and literature review. J Neurol Surg A Cent Eur Neurosurg 2016; 77 (03) 274-279
• 16 Takeuchi S, Kageyama H, Tsuzuki N. et al. Posterior reversible encephalopathy syndrome. J Neurosurg Pediatr 2011; 8 (05) 535
• 17 Bartynski WS. Posterior reversible encephalopathy syndrome, part 2: controversies surrounding pathophysiology of vasogenic edema. AJNR Am J Neuroradiol 2008; 29 (06) 1043-1049
• 18 Marra A, Vargas M, Striano P, Del Guercio L, Buonanno P, Servillo G. Posterior reversible encephalopathy syndrome: the endothelial hypotheses. Med Hypotheses 2014; 82 (05) 619-622
• 19 Fisler G, Monty MA, Kohn N, Assaad P, Trope R, Kessel A. Characteristics and outcomes of critically ill pediatric patients with posterior reversible encephalopathy syndrome. Neurocrit Care 2020; 32 (01) 145-151